Company Filing History:
Years Active: 1992-1997
Title: The Innovative Mind of Hans Schweingruber
Introduction
Hans Schweingruber is a prominent inventor based in Mountain View, CA, known for his significant contributions to medical science through his innovative patents. With a total of six patents to his name, Schweingruber focuses on methods for treating inflammation, employing novel binding compounds to combat various conditions.
Latest Patents
Among his latest patents, one noteworthy innovation is centered around methods of treating inflammation using selection binding compounds. This patent reveals novel ligands that bind specifically to human selectin receptors, formulated with excipient carriers to create compositions intended for the treatment of inflammation. These ligands are characterized by their structural formula, enabling them to form hydrogen bonds with selectins under physiological conditions.
Another recent patent from Schweingruber addresses carbohydrate-based anti-inflammatory agents. This development involves ligands in the form of N-acetyllactosamines, which target the endothelial leukocyte adhesion molecule-1 (ELAM-1). The ligand compounds can be incorporated into pharmaceutical and assay compositions aimed at alleviating inflammation, as well as determining the presence, location, and degree of inflammation through qualitative and quantitative assessments of ELAM-1.
Career Highlights
Schweingruber is currently associated with Glycomed, Inc., where he continues to push the boundaries of medical innovation. His work is instrumental in advancing therapeutic strategies that address inflammatory conditions, showcasing his dedication to improving healthcare through his inventions.
Collaborations
Throughout his career, Hans Schweingruber has collaborated with notable coworkers, including Brian K. Brandley and Michael Tiemeyer. These partnerships emphasize the importance of teamwork in the innovation process, as they work together to translate scientific breakthroughs into practical applications.
Conclusion
Hans Schweingruber's contributions to the realm of medical science through his patents signify his role as an influential inventor. With a focus on treating inflammation through innovative compounds, his work at Glycomed, Inc. illustrates the positive impact of collaborative efforts in the field of healthcare innovation. As he continues to develop cutting-edge solutions, Schweingruber remains a key figure in the pursuit of advanced medical treatments.